Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Metrics to compare | AIFF | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipAIFFPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.4x | −1.1x | −0.5x | |
PEG Ratio | - | −0.01 | 0.00 | |
Price/Book | 7.0x | 1.2x | 2.6x | |
Price / LTM Sales | 262.4x | 1.8x | 3.3x | |
Upside (Analyst Target) | - | 21.3% | 42.8% | |
Fair Value Upside | Unlock | 17.0% | 6.5% | Unlock |